low density lipoprotein (MedChemExpress)
94
Structured Review
MedChemExpress
low density lipoprotein
Low Density Lipoprotein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-np012/Low+density+lipoprotein/pmc08178257-32-37-35
Average 94 stars, based on 12 article reviews
Low Density Lipoprotein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-np012/Low+density+lipoprotein/pmc08178257-32-37-35
Average 94 stars, based on 12 article reviews
low density lipoprotein - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Membrane:Article Title: Uncovering the mechanism of Buyang Huanwu Decoction in regulating mitochondrial dysfunction to alleviate atherosclerosis: BTK, PREPL, and P2RX7 proteins play key roles. Article Snippet: The purpose of this study was to uncover key target proteins and corresponding active ingredients of Buxue Huanwu Decoction (BYHWD) on improving mitochondrial function to alleviate atherosclerosis (AS) via construction of a novel strategy based on in silico virtual screening, UHPLC-Q-TOF-MS/MS, and experimental verification.. Firstly, 57 compounds of BYHWD were identified using UHPLC-Q-TOF-MS/MS technology, followed by the selection of 13 candidate compounds using Druggability predictions.. Subsequently, a combination of differentially expressed genes (DEGs), weighted gene co-expression network analysis (WGCNA), and machine learning methods were employed to identify three hub genes associated with mitochondrial function and AS, including BTK, P2RX7 and PREPL. Cell Culture:Article Title: Inhibition of LXR Signaling in Human Foam Cells Impairs Macrophage-to-Endothelial Cell Cross Talk and Promotes Endothelial Cell Inflammation Article Snippet: Human monocytes were differentiated into macrophages for 6 days with 50 ng/mL of M-CSF (CSF1 [colony-stimulating factor 1]; Miltenyi Biotec; catalog No. 130-093-963) into RPMI (Roswell Park Memorial Institute) 1640 medium (GIBCO; Fisher Scientific, Strasbourg, France) supplemented with 10% fetal bovine serum in 5% CO 2 and 37 °C. .. On day 6, hMDMs were treated for 48 hours with 1 of the following treatments: whole atherosclerotic plaque extracts (1% v/v in cell culture medium), 10 μmol/L 27-hydroxycholesterol (27OHC; Avanti Polar Lipids; Sigma; France; catalog No. 20380-11-4), or 50 μg/mL oxidized Article Title: Inhibition of LXR Signaling in Human Foam Cells Impairs Macrophage-to-Endothelial Cell Cross Talk and Promotes Endothelial Cell Inflammation Article Snippet: 910 June 2025 Arterioscler Thromb Vasc Biol.. 2025;45:910–927.. DOI: 10.1161/ATVBAHA.125.322448 Arterioscler Thromb Vasc Biol is available at www.ahajournals.org/journal/atvb Correspondence to: David Masson, PharmD, PhD, Université Bourgogne Europe, UMR1231, UFR des Sciences de Santé – bureau R26, 7 boulevard Jeanne d’Arc, 21000 Dijon, France, Email david.masson@chu-dijon.fr; or Damien Leleu, PharmD, PhD, Université Bourgogne Europe UMR1231, UFR des Sciences de Santé – bureau R26, 7 boulevard Jeanne d’Arc, 21000 Dijon, France, Email damien.leleu@u-bourgogne.fr Supplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/ATVBAHA.125.322448. Cholesterol Assay:Article Title: Synergistic effects of notoginsenoside R1 and saikosaponin B2 in atherosclerosis: A novel approach targeting PI3K/AKT/mTOR pathway and macrophage autophagy Article Snippet: Notoginsenoside R1 (NGR1, chemical structure C 47 H 80 O 18 , molecular weight = 933 g/mol, purity = 99.5%, BD2143) and saikosaponin B2 (SSB2, chemical structure C 42 H 68 O 13 , molecular weight = 781 g/mol, purity = 99.5%, BD150742 ) were purchased from bidepharm(Shanghai,China). .. Additionally, the following reagents were purchased:Oxidized Article Title: Synergistic effects of notoginsenoside R1 and saikosaponin B2 in atherosclerosis: A novel approach targeting PI3K/AKT/mTOR pathway and macrophage autophagy. Article Snippet: Notoginsenoside R1 (NGR1, chemical structure C 47 H 80 O 18 , molecular weight = 933 g/mol, purity = 99.5%, BD2143) and saikosaponin B2 (SSB2, chemical structure C 42 H 68 O 13 , molecular weight = 781 g/mol, purity = 99.5%, BD150742) were purchased from bidepharm(Shanghai,China). .. Additionally, the following reagents were purchased:Oxidized Recombinant:Article Title: Integrated Transcriptomic and Functional Analyses Reveal lncRNA-miRNA-mRNA Axis in AML Relapse After Allo-HSCT. Article Snippet: .. See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense 3Cancer Science, 2026 SFEM II (StemCell#09605), or IMDM (Gibco#12440053), supplemented as indicated with recombinant human cytokines and additives, including SCF (StemCell #78062), FLT3L (Miltenyi#130–096- 474), TPO (StemCell #78210.1), IL- 6 (MCE# HY- P7044), IL- 3 (MCE# HY- P70576), G- CSF (MCE# HY- P73523), Article Title: Integrated Transcriptomic and Functional Analyses Reveal lncRNA ‐ miRNA ‐ mRNA Axis in AML Relapse After Allo‐ HSCT Article Snippet: CD34 + cells were magnetically isolated using CD34 MicroBeads with MS/LS columns on a magnetic separator in PBS containing 0.5% BSA and 2 mM EDTA. .. Cells were maintained in one of the following media: MyeloCult H5100 (StemCell#05150), StemSpan SFEM II (StemCell#09605), or IMDM (Gibco#12440053), supplemented as indicated with recombinant human cytokines and additives, including SCF (StemCell #78062), FLT3L (Miltenyi#130–096‐474), TPO (StemCell #78210.1), IL‐6 (MCE# HY‐P7044), IL‐3 (MCE# HY‐ P70576 ), G‐CSF (MCE# HY‐ P73523 ), Clinical Proteomics:Article Title: Integrated Transcriptomic and Functional Analyses Reveal lncRNA-miRNA-mRNA Axis in AML Relapse After Allo-HSCT. Article Snippet: .. See the T erm s and C onditions (https://onlinelibrary.w iley.com /term s-and-conditions) on W iley O nline L ibrary for rules of use; O A articles are governed by the applicable C reative C om m ons L icense 3Cancer Science, 2026 SFEM II (StemCell#09605), or IMDM (Gibco#12440053), supplemented as indicated with recombinant human cytokines and additives, including SCF (StemCell #78062), FLT3L (Miltenyi#130–096- 474), TPO (StemCell #78210.1), IL- 6 (MCE# HY- P7044), IL- 3 (MCE# HY- P70576), G- CSF (MCE# HY- P73523), Concentration Assay:Article Title: Multi-Omics Analysis Combined with Machine Learning Identified FABP4 in Smooth Muscle Cells as a Pathogenic Factor in Atherosclerosis Article Snippet: .. Murine aortic vascular smooth muscle cells (MOVAS) (ATCC, No. CRL-2797 TM ) were treated with a 25 μg/mL concentration of oxidized |